Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trial

1. Smolen, J.S.
2. Cohen, S.B.
3. Tony, H.-P.
4. Scheinberg, M.
5. Kivitz, A.
6. Balanescu, A.
7. Gomez-Reino, J.
8. Cen, L.
9. Poetzl, J.
10. Shisha, T.
11. Kollins, D.